Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership.

Trypanosoma brucei clinical trial efficiency clinical trial operations clinical trial planning drug discovery human African trypanosomiasis nitroimidazole product development partnership sleeping sickness

Journal

Diseases (Basel, Switzerland)
ISSN: 2079-9721
Titre abrégé: Diseases
Pays: Switzerland
ID NLM: 101636232

Informations de publication

Date de publication:
17 Oct 2022
Historique:
received: 25 08 2022
revised: 04 10 2022
accepted: 07 10 2022
entrez: 24 10 2022
pubmed: 25 10 2022
medline: 25 10 2022
Statut: epublish

Résumé

After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenges of the clinical trials of fexinidazole. The screening of the Drugs for Neglected Diseases initiative (DNDi) HAT-library by the Swiss TPH had singled out fexinidazole, originally developed by Hoechst (now Sanofi), as the most promising of a series of over 800 nitroimidazoles and related molecules. In cell culture, fexinidazole has an IC

Identifiants

pubmed: 36278589
pii: diseases10040090
doi: 10.3390/diseases10040090
pmc: PMC9589988
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Swiss National Science Foundation
ID : 310030_156264
Pays : Switzerland

Références

Acta Trop. 1993 Sep;54(3-4):153-62
pubmed: 7902654
Lancet Glob Health. 2022 Nov;10(11):e1665-e1674
pubmed: 36179736
PLoS Negl Trop Dis. 2016 Feb 16;10(2):e0004362
pubmed: 26881924
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5022-7
pubmed: 18367671
Br Med Bull. 1985 Apr;41(2):130-6
pubmed: 2992672
Trends Parasitol. 2014 Jun;30(6):289-98
pubmed: 24776300
Int J Health Geogr. 2009 Mar 18;8:15
pubmed: 19296837
Pharmaceuticals (Basel). 2022 Jan 21;15(2):
pubmed: 35215241
ACS Infect Dis. 2021 Oct 8;7(10):2777-2786
pubmed: 34472830
Science. 1980 Oct 17;210(4467):332-4
pubmed: 6775372
Ann Trop Med Parasitol. 1983 Feb;77(1):13-26
pubmed: 6411009
Mutagenesis. 2012 Sep;27(5):523-32
pubmed: 22539226
Lancet. 2009 Jul 4;374(9683):56-64
pubmed: 19559476
Lancet. 2010 Jan 9;375(9709):148-59
pubmed: 19833383
Lancet. 1999 Apr 3;353(9159):1113-4
pubmed: 10209970
Lancet Glob Health. 2021 Jul;9(7):e999-e1008
pubmed: 34143998
Lancet. 1992 Sep 12;340(8820):652-5
pubmed: 1355219
Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31844000
Br Med Bull. 1998;54(2):341-55
pubmed: 9830201
Nat Rev Microbiol. 2014 Aug;12(8):575-84
pubmed: 24975321
Am J Trop Med Hyg. 1949 Mar;29(2):173-80
pubmed: 18116843
Future Microbiol. 2011 Sep;6(9):1037-47
pubmed: 21958143
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30670439
Trop Med Infect Dis. 2020 Jan 19;5(1):
pubmed: 31963784
Lancet. 2001 Aug 25;358(9282):625-8
pubmed: 11530149
Z Parasitenkd. 1983;69(5):577-81
pubmed: 6636983
Arzneimittelforschung. 1978;28(5):739-49
pubmed: 107955
Antimicrob Agents Chemother. 2011 Dec;55(12):5602-8
pubmed: 21911566
PLoS One. 2017 Mar 16;12(3):e0173796
pubmed: 28301530
Trop Med Int Health. 2015 Jun;20(6):707-18
pubmed: 25694261
Bull World Health Organ. 2000;78(11):1284-95
pubmed: 11143188
Clin Epidemiol. 2014 Aug 06;6:257-75
pubmed: 25125985
Lancet. 2018 Jan 13;391(10116):144-154
pubmed: 29113731
J Epidemiol Glob Health. 2020 Dec;10(4):280-287
pubmed: 32959623
Trends Parasitol. 2013 Mar;29(3):110-8
pubmed: 23375541
Science. 2005 Jul 15;309(5733):416-22
pubmed: 16020726
Glob Health Res Policy. 2017 Apr 07;2:11
pubmed: 29202079
PLoS Negl Trop Dis. 2020 May 21;14(5):e0008261
pubmed: 32437391
PLoS Negl Trop Dis. 2016 Feb 16;10(2):e0004363
pubmed: 26882015
Health Policy Plan. 2020 Apr 1;35(3):323-333
pubmed: 31942625
PLoS Negl Trop Dis. 2022 Jan 18;16(1):e0010047
pubmed: 35041668
Malar J. 2021 Jun 24;20(1):281
pubmed: 34167536
Trop Med Int Health. 2016 Aug;21(8):1040-1048
pubmed: 27260671
PLoS Negl Trop Dis. 2010 Dec 21;4(12):e923
pubmed: 21200426
Eur J Med Chem. 2011 May;46(5):1524-35
pubmed: 21353728
Acta Trop. 1993 Sep;54(3-4):279-89
pubmed: 7902665
Antimicrob Agents Chemother. 2009 Oct;53(10):4185-92
pubmed: 19620327
Lancet. 2006 Apr 29;367(9520):1377-8
pubmed: 16650633

Auteurs

Sonja Bernhard (S)

Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.
University of Basel, 4002 Basel, Switzerland.

Marcel Kaiser (M)

Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.
University of Basel, 4002 Basel, Switzerland.

Christian Burri (C)

Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.
University of Basel, 4002 Basel, Switzerland.

Pascal Mäser (P)

Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland.
University of Basel, 4002 Basel, Switzerland.

Classifications MeSH